SecurityAKRX / Akorn, Inc.
InstitutionCantab Capital Partners LLP
Shares12,561
Value $ 417,000,000
Related 009728AB2 / Akorn, Inc. Bond

Cantab Capital Partners LLP ownership in AKRX / Akorn, Inc.

November 14, 2017 - Cantab Capital Partners LLP has filed a 13F-HR form disclosing ownership of 12,561 shares of Akorn, Inc. (NASDAQ:AKRX) with total holdings valued at $417,000,000 USD as of September 30, 2017.

Akorn, Inc. has declared a standard industrial code (sic) of 2834 which is the "Pharmaceutical Preparations" industry. Cantab Capital Partners LLP's top industries are "Pipelines, Except Natural Gas" (sic 46), "Oil And Gas Extraction" (sic 13), and "Automotive Repair, Services, And Parking" (sic 75).

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2017-09-30 13F-HR AKORN INC CMN COM 009728106 12,561 417,000

Related SEC Filings

AKRX / Akorn, Inc. / PAULSON & CO. INC. - FEBRUARY 14, 2018 (Passive Investment)

2018-02-15 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.  20549 SCHEDULE 13G (RULE 13d - 102)* INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 1)* AKORN, INC. (Name of Issuer) Common stock, no par value (Title of Class of Securities) 009728106 (CUSIP Number) December 31, 2017 (Date of Event which Requires Filing of this Statement) Check the appropriat (0-2)

AKRX / Akorn, Inc. / PAULSON & CO. INC. - FEBRUARY 14, 2018 (Passive Investment)

2018-02-16 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.  20549 SCHEDULE 13G (RULE 13d - 102)* INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 1)* AKORN, INC. (Name of Issuer) Common stock, no par value (Title of Class of Securities) 009728106 (CUSIP Number) December 31, 2017 (Date of Event which Requires Filing of this Statement) Check the appropriat

AKRX / Akorn, Inc. / FMR LLC / Fidelity - 3G (Passive Investment)

2018-02-13 sec.gov
SCHEDULE 13G Amendment No. 0 AKORN INC COMMON STOCK Cusip #009728106 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #009728106 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 11,520,559 Item 6: 0 Item 7: 11,618,549 Item 8: 0 Item 9: 11,618,549 Item 11: 9.289% Item 12: HC Cusip #009728106 Item 1: Reporting Person - Abigail P. (0-1)

AKRX / Akorn, Inc. / FMR LLC / Fidelity - 3G (Passive Investment)

2018-02-13 sec.gov
SCHEDULE 13G Amendment No. 0 AKORN INC COMMON STOCK Cusip #009728106 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #009728106 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 11,520,559 Item 6: 0 Item 7: 11,618,549 Item 8: 0 Item 9: 11,618,549 Item 11: 9.289% Item 12: HC Cusip #009728106 Item 1: Reporting Person - Abigail P.

AKRX / Akorn, Inc. / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-08 sec.gov
akorninc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 1 )*       Name of issuer:  Akorn Inc     Title of Class of Securities:  Common Stock     CUSIP Number:  009728106     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (X) Rule 13d-1(b)   (  )

Related News Stories

Stock Exchange: Do You Pretend To Understand The Market?

2018-10-12 seekingalpha
There are plenty of media pundits ready with plausible explanations after every market sell-off, but if they really understood the causes, why'd they wait until after the sell-off to explain? (23-1)

Worst-Performing Stocks This Month

2018-10-11 seekingalpha
The average stock in the S&P 1500 was up 9.24% year-to-date through September, but October has been brutal for stocks thus far. On the surface, the S&P 1500 is only down 1.4% month-to-date, but what lies beneath is much worse. As shown in the chart below, the average stock in the index has fallen 2.75% this month, and cyclical sectors have taken it on the chin even harder. (18-0)

Merger Arbitrage Mondays - October 8, 2018

2018-10-08 seekingalpha
Fresenius won a court ruling allowing the healthcare group to walk away from its takeover of Akorn. (38-2)

Snap, Akorn Dive into Monday’s 52-Week Low Club

2018-10-01 247wallst
October 1, 2018: Here are four stocks trading with heavy volume among 127 equities making new 52-week lows in Monday’s session. On the NYSE advancers led decliners by about 1.5 to 1, and on the Nasdaq, decliners led advancers by about 1.81 to 1. (166-1)

REFILE-UPDATE 2-Delaware judge says Fresenius can walk away from $4.8 bln Akorn deal

2018-10-01 reuters
WILMINGTON, Del (Reuters) - Germany’s Fresenius SE (FREG.DE) won a rare court ruling allowing the healthcare group to walk away from its $4.75 billion takeover of Akorn Inc (AKRX.O), sparking a more than 50 percent fall in the U.S. generic drugmaker’s shares. (9-4)



CUSIP: 009728106